Reasoned opinion on the modification of the existing MRL for kresoxim-methyl in azaroles

In accordance with Article 6 of Regulation (EC) No 396/2005, Belgium, hereafter referred to as the evaluation Member State (EMS), compiled an application to modify the existing MRL for the active substance kresoxim-methyl in azaroles. In order to accommodate for the intended uses in EU of kresoxim-methyl, Belgium proposed to raise the existing MRL from the limit of quantification (LOQ) of 0.05* mg/kg to 0.9 mg/kg. Belgium drafted an evaluation report in accordance with Article 8 of Regulation (EC) No 396/2005, which was submitted to the European Commission and forwarded to EFSA. According to EFSA the data were sufficient to derive a MRL proposal of 0.9 mg/kg for azaroles. Adequate analytical enforcement methods are available to control the residues of kresoxim-methyl on the commodity under consideration at the validated LOQ of 0.01 mg/kg. Based on the risk assessment results, EFSA concludes that the proposed use of kresoxim methyl on azaroles will not result in a consumer exposure exceeding the toxicological reference value and therefore, is unlikely to pose a consumer health risk.